Section 05: Business Model & Economics
MedMinder Pro - Financial Viability & Monetization Strategy
Unit Economics Summary (Target Maturity)
1. Revenue Model Overview
B2B Health Plan Licensing
Contribution: ~60% of Revenue
Rationale: Value-based care contracts force payers to reduce hospitalizations. By reducing readmissions (avg cost $15k), a $3.50 PMPM fee offers immediate ROI. This model provides predictable, high-volume revenue and aligns incentives directly with the customer.
Consumer Freemium (B2C)
Contribution: ~30% of Revenue
Rationale: Validates product-market fit and generates real-world adherence data to prove value to B2B partners. Low friction ($4.99/mo) allows broad market penetration while premium features (caregiver access, pharmacy sync) drive conversion.
Pharma Partnerships
Contribution: ~10% of Revenue
Rationale: Specialty drug manufacturers lose billions to non-adherence. Co-marketing programs for high-cost biologics provide a high-margin revenue stream without significant additional engineering effort.
2. Pricing Strategy & Tier Structure
Consumer (B2C) Tiers
| Tier | Target | Price | Key Features | Conversion Goal |
|---|---|---|---|---|
| Free | Trial/Solo users | $0 | Smart Reminders, 5 Meds, Basic Tracking | 5% → Premium |
| Premium | Patients, Caregivers | $4.99/mo | Unlimited Meds, Caregiver Dashboard, Root Cause Insights, Pharmacy Sync | Retention > 85% |
| Annual | Committed Users | $49/yr | All Premium Features (2 Months Free) | Lock-in cash flow |
B2B Licensing (PMPM)
| Segment | Price Model | Contract Value | Justification |
|---|---|---|---|
| Regional Health Plan | $3.50 PMPM | $210k / year (5k members) | Targeted at high-risk chronic populations to reduce ER utilization. |
| National Payer | $2.00 PMPM | $2.4M / year (100k members) | Volume discount for broader implementation across Medicare Advantage. |
The $4.99 price point is deliberately set below the "psychological barrier" of $5.00, positioning MedMinder as an essential utility (less than a coffee) rather than a luxury medical device. This minimizes friction for seniors on fixed incomes. For B2B, pricing is strictly ROI-linked: preventing a single hospitalization (~$15,000) pays for the license for ~350 members for a full year.
3. Customer Acquisition Economics
B2C Channels (Consumer)
| Channel | CAC | Notes |
|---|---|---|
| Content/SEO | $12 | High intent, long tail |
| Social Ads (FB/IG) | $25 | Targeting caregivers 40-60 |
| Referral Program | $5 | 1 month free credit |
| Blended B2C CAC | $18 | Weighted Avg |
B2B Channels (Enterprise)
| Channel | CAC | Notes |
|---|---|---|
| Conferences/Events | $2,500 | Booth + travel |
| Direct Sales | $5,000 | Commission + legal |
| Pilot Programs | $15,000 | Implementation cost |
| Per Contract CAC | $8,500 | High initial, low churn |
4. Lifetime Value (LTV) Analysis
Consumer LTV
- ARPU: $4.50 (net of fees)
- Monthly Churn: 8% (Target)
- Lifespan: 12.5 Months
Payback: ~4 months
B2B Contract LTV
- Avg Contract Value: $210,000/yr
- Annual Churn: 10%
- Lifespan: 10 Years
Payback: Immediate (first month)
5. Cost Structure & Margins
Fixed Costs (Monthly Burn)
| Personnel (2.5 FTE) | $35,000 |
| Clinical Advisor | $6,250 |
| Software & Infrastructure | $2,000 |
| Legal/Compliance | $2,000 |
| Total Monthly Fixed | $45,250 |
Variable Costs (Per User/Month)
| Cloud Hosting (HIPAA) | $0.50 |
| AI/NLP Processing | $0.40 |
| SMS Notifications (Twilio) | $0.10 |
| Payment Processing | $0.30 |
| Total Variable (COGS) | $1.30 |
Gross Margin Analysis
With a consumer price of $4.99 and variable costs of $1.30, the Gross Margin is 74%. B2B margins are significantly higher (90%+) as infrastructure costs scale linearly while revenue scales exponentially with member count.
6. Financial Projections & Break-Even
| Metric | Year 1 (Build) | Year 2 (Pilot) | Year 3 (Scale) |
|---|---|---|---|
| B2C Paying Users | 1,200 | 5,500 | 15,000 |
| B2B Covered Lives | 0 | 10,000 | 150,000 |
| Total ARR | $72,000 | $475,000 | $2.8M |
| Gross Margin | 65% | 75% | 85% |
| OpEx (Burn) | ($540,000) | ($900,000) | ($2.1M) |
| Net Profit/Loss | ($468,000) | ($425,000) | +$280,000 |
Break-Even Point
Based on current seed ask of $750K. Requires closing 1 mid-sized B2B contract (5k members) and reaching 4k B2C subscribers.
Cash Flow Positive
Assumes successful Series A raise to accelerate sales team hiring in Year 2 to support Year 3 B2B expansion.
7. Funding Strategy & Use of Funds
8. Regulatory & Risk Assessment
Regulatory Compliance
Full BAA (Business Associate Agreement) workflow required. AWS infrastructure must be configured for HIPAA (encrypted at rest/transit). Estimated Cost: $10k setup + $3k/yr audit.
Positioning as a "Wellness" tool to avoid Class II Medical Device registration. We do not alter dosage or diagnosis, we only prompt adherence.
Business Risks
Enterprise sales can take 12-18 months, exhausting runway before revenue materializes.
Mitigation:
Pursue regional health plans and pharmacy partners (B2B2C) with faster decision cycles. Use B2C revenue to extend runway.
Target demographic (50+) may struggle with app UX or resist behavior change.
Mitigation:
Design for accessibility (large text, high contrast). Onboarding flow involves caregiver setup. Voice-first interface (Alexa/Siri) integration.
User misses dose due to app failure or takes wrong dose based on bad data.
Mitigation:
Strong Terms of Service disclaiming medical advice. Cyber Liability insurance ($3M coverage). Manual verification prompts for high-risk meds.
9. Alternative Models Considered
Alternative 1: Pure B2C (No Enterprise)
Rejected: While easier to launch, CAC in health/fitness apps is rising ($25-$50). The LTV of a $4.99 subscription is too low to sustain a company with heavy R&D and compliance costs. The "Big Exit" in digital health requires B2B contracts.
Alternative 2: Hardware-Enabled (Smart Pill Box)
Rejected: Hardware increases inventory risk, logistics complexity, and lowers margins significantly. Software-only approach allows for faster iteration and global scalability without shipping physical goods.